参考文献/References:
[1]杨媚. FGF-21 的研究进展 [J].医学教育探索,2009,8(3):336-338.
[2]Wu X , Ge H , Baribault H , et al .Dual actions of fibroblast growth factor 19 on lipid metabolism [J].J Lipid Res ,2013,54(2):325-332.
[3]American Diabetes Association. Standards of medical care in diabete—2011 [J]. Diabetes Care,2011 , 34 (1):S11-S61.
[4]韩颖文 . 妊娠期糖尿病与糖耐量异常的早期行为干预对妊娠结局的临床探讨 [J].中国实验诊断学,2014,18(7):1148-1150.
[5]Inturrisi M, Lintner N C, Sorem K A. Diagnosis and treatment of hyperglycemia in pregnancy [J]. Endocrinol Metab Clin North Am,2011,40 (4):703 -726.
[6]Saucedo R,Zarate A,Basurto L,et al. Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes[J].Archives of Medical Research ,2011,42(4):318 -323.
[7]Itoh N.Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development,metabolism, and disease [J]. Cell Tissue Res, 2010, 342 (1):1-11.
[8]Ryan K K, Kohli R, Gutierrez-Aguilar R, et al. Fibroblast Growth Factor-19 Action in the Brain Reduces Food Intake and Body Weight and Improves Glucose Tolerance in Male Ra[J].Endocrinology, 2013, 154 (1):9-15.
[9]侯玉婷,李晋南,任桂萍,等.人FGF-21基因的克隆、表达及调节脂肪细胞糖代谢的活性 [J].遗传,2010,32(6):583-587.
[10]Berglund ED, lI CY, Bina HA, et al. Fibroblast Growth Factor-21 controls glycemia via regulation of hepatic glucose flux and insulin sensitvity[J]. Endocrinology, 2009, 150(9):4084-4093.
[11]徐彤宇,王文飞,李德山 ,等. 成纤维细胞生长因子 21 对胰岛素抵抗缓解作用机制的研究[J]. 药学学报, 2015,50(9):1101-1106.
相似文献/References:
[1]程兰.妊娠期糖代谢异常患者血清胱抑素C测定的意义[J].中国计划生育和妇产科,2010,(06):0.
CHENG Lan Tianjin Centtal Gynaecology and Obstetrics Hospital of,Tianjin 0000,China.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(12):0.
[2]陈茜松,刘丽俊,季淑英,等.妊娠期高血压疾病患者血清抵抗素水平的变化及其临床意义[J].中国计划生育和妇产科,2011,(03):0.
CHEN Qian-song,LIU Li-jun,JI Shu-ying.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(12):0.
[3]赵昆.D-二聚体测定在产科常见病理性高凝状态疾病的临床意义[J].中国计划生育和妇产科,2011,(04):0.
ZHAO Kun.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(12):0.
[4]潘玥,刘巧,朱绍密,等.妊娠期糖尿病胰岛素治疗的临床分析[J].中国计划生育和妇产科,2011,(06):0.
PAN Yue,LIU Qiao,ZHU Shao-mi.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(12):0.
[5]任涛,熊小英,蔡春芳,等.多囊卵巢综合征患者视黄醇结合蛋白-4的水平变化及意义[J].中国计划生育和妇产科,2013,(04):0.
REN Tao *,XIONG Xiao-ying,CAI Chun-fang.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[6]黎凤彩,苏凌春,曾志娟,等.血清胱抑素C联合血清尿酸在监测妊娠期糖尿病发生妊娠期高血压疾病的临床意义[J].中国计划生育和妇产科,2013,(05):0.
LI Feng-cai,SU Ling-chun,ZENG Zhi-juan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[7]郝梅花,谢梅青.无排卵和子宫内膜病变关系的研究进展[J].中国计划生育和妇产科,2014,(03):0.
Hao Mei-hua,Xie Mei-qing,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(12):0.
[8]王秋毅,黄薇.多囊卵巢综合征的代谢障碍[J].中国计划生育和妇产科,2014,(06):0.
[9]王国育.妊娠期糖尿病孕妇孕前体质量指数对分娩方式和新生儿体质量的影响[J].中国计划生育和妇产科,2014,(07):0.
WANG Guo-yu,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(12):0.
[10]赵卓姝,关海兰,何洁云,等.孕期个性化营养指导对妊娠期糖尿病患者妊娠结局的影响[J].中国计划生育和妇产科,2014,(08):0.
ZHAO Zhuo-shu,GUAN Hai-lan,HE Jie-yun,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(12):0.
[11]杨帆,蒋晓岚,王佳,等.年龄对二次妊娠期糖尿病的胰岛素抵抗及胰岛β细胞功能影响的研究[J].中国计划生育和妇产科,2016,(04):0.
YANG Fan,JIANG Xiao-lan,WANG Jia,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(12):0.
[12]芦笛,白伶俐.妊娠期糖尿病合并多囊卵巢综合征患者的不良临床结局分析[J].中国计划生育和妇产科,2016,(10):0.
LU Di,BAI Lin-lird.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(12):0.
[13]王涛*,赵倩,侯倩男,等.内脂素在妊娠期糖尿病患者中的检测价值[J].中国计划生育和妇产科,2017,(3):65.
WANG Tao*,ZHAO Qian,HOU Qian-nan,et al.The detective value of serum visfatin in patients with gestational diabetes mellitus[J].Chinese Journal of Family Planning & Gynecotokology,2017,(12):65.
[14]杨静*,王祥珍,杨建恩.妊娠期糖尿病患者血清脂联素、趋化素、视黄醇结合蛋白4与胰岛素抵抗的关系[J].中国计划生育和妇产科,2018,(7):74.
YANG Jing*,WANG Xiang-zhen,YANG Jian-en.Relationship between serum adiponectin, chemerin, retinol binding
protein 4 and insulin resistance in patients with gestational
diabetes mellitus[J].Chinese Journal of Family Planning & Gynecotokology,2018,(12):74.